These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34020293)

  • 21. Challenges in TB control and the anticipated COVID-19 third wave: Way forward.
    Padmapriyadarsini C; Banurekha V; Arora VK
    Indian J Tuberc; 2021 Oct; 68(4):425-427. PubMed ID: 34752307
    [No Abstract]   [Full Text] [Related]  

  • 22. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
    Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
    Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 and second wave: can India become self-sufficient in vaccines?
    Shekhar SK; Jose TP
    Hum Vaccin Immunother; 2021 Nov; 17(11):4131. PubMed ID: 34542382
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccine certificate during domestic traveling: a potential initiative to prevent COVID-19 waves in India.
    Choudhary OP; Priyanka ; Singh I
    Hum Vaccin Immunother; 2021 Oct; 17(10):3487-3488. PubMed ID: 34170790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic.
    Gambhir RS; Aggarwal A; Bhardwaj A; Kaur A; Sohi RK; Mehta S
    Rocz Panstw Zakl Hig; 2021; 72(3):239-244. PubMed ID: 34553877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India?
    Tempe DK
    Lancet Infect Dis; 2021 Oct; 21(10):1349-1350. PubMed ID: 34450054
    [No Abstract]   [Full Text] [Related]  

  • 27. Tuberculosis management in India during COVID-19 crisis.
    Awasthi AK; Singh PK
    J Public Health Policy; 2021 Mar; 42(1):185-189. PubMed ID: 33235251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19: The battle of Maharashtra.
    Lahane T
    Indian J Ophthalmol; 2021 Mar; 69(3):477-478. PubMed ID: 33595457
    [No Abstract]   [Full Text] [Related]  

  • 29. The SARS-CoV-2/COVID-19 pandemic and challenges in stroke care in India.
    Sylaja PN; Srivastava MVP; Shah S; Bhatia R; Khurana D; Sharma A; Pandian JD; Kalia K; Sarmah D; Nair SS; Yavagal DR; Bhattacharya P
    Ann N Y Acad Sci; 2020 Aug; 1473(1):3-10. PubMed ID: 32396683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Containment strategies for COVID-19 in India: lessons from the second wave.
    Asrani P; Tiwari K; Eapen MS; Hassan MDI; Sohal SS
    Expert Rev Anti Infect Ther; 2022 Jun; 20(6):829-835. PubMed ID: 35098855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delta threatens rural regions that dodged earlier COVID waves.
    Mallapaty S
    Nature; 2021 Aug; 596(7872):325-326. PubMed ID: 34354278
    [No Abstract]   [Full Text] [Related]  

  • 32. Protocol for a prospective, hospital-based registry of pregnant women with SARS-CoV-2 infection in India: PregCovid Registry study.
    Gajbhiye RK; Mahajan NN; Waghmare R; Surve SV; Howal P; Bhurke A; Pious M; Modi DN; Mahale SD
    BMJ Open; 2022 Mar; 12(3):e050039. PubMed ID: 35301200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colossal challenges to healthcare workers combating the second wave of coronavirus disease 2019 (COVID-19) in India.
    Ghosh S; Moledina N; Hasan MM; Jain S; Ghosh A
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1302-1303. PubMed ID: 34075871
    [No Abstract]   [Full Text] [Related]  

  • 34. Pandemic lessons from India.
    Reddy KS
    BMJ; 2021 May; 373():n1196. PubMed ID: 33980588
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of preoperative COVID infection on the outcomes of planned curative-intent cancer surgeries in the second wave of the pandemic from a tertiary care center in India.
    Pandrowala S; Ramraj D; Shankar R; Chopra S; Das A; Mishra A; Pandey D
    J Surg Oncol; 2022 Feb; 125(2):107-112. PubMed ID: 34569620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India? - Authors' reply.
    Udwadia Z; Balsari S; Ghafur A
    Lancet Infect Dis; 2021 Oct; 21(10):1350. PubMed ID: 34450052
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased rate of miscarriage during second wave of COVID-19 pandemic in India.
    Gajbhiye RK; Tilve A; Kesarwani S; Srivastava S; Kore SJ; Patil K; Mahale SD; Mahajan NN
    Ultrasound Obstet Gynecol; 2021 Dec; 58(6):946-949. PubMed ID: 34580950
    [No Abstract]   [Full Text] [Related]  

  • 38. Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia.
    Lenicek Krleza J; Zrinski Topic R; Stevanovic V; Lukic-Grlic A; Tabain I; Misak Z; Roic G; Kaic B; Mayer D; Hruskar Z; Barbic L; Vilibic-Cavlek T
    Biochem Med (Zagreb); 2021 Jun; 31(2):020706. PubMed ID: 33927556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of mobile application-based teleophthalmology services across India during the COVID-19 pandemic.
    Ravulaparthi G; Chelluri S
    Indian J Ophthalmol; 2021 Apr; 69(4):996-997. PubMed ID: 33727478
    [No Abstract]   [Full Text] [Related]  

  • 40. Large-scale synchronized replacement of Alpha (B.1.1.7) variant by the Delta (B.1.617.2) variant of SARS-COV-2 in the COVID-19 pandemic.
    Liu Y; Feng A; Zhao S; Wang W; He D
    Math Biosci Eng; 2022 Feb; 19(4):3591-3596. PubMed ID: 35341265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.